Literature DB >> 23530907

Pertussis re-emergence in the post-vaccination era.

Elena Chiappini1, Alessia Stival, Luisa Galli, Maurizio de Martino.   

Abstract

BACKGROUND: Resurgence of pertussis in the post-vaccination era has been reported in Western countries. A shift of cases from school-age children to adolescents, adults and children under 1 year of age has been described in the last decade, and mortality rates in infants are still sustained. We aimed to review and discuss the possible vaccination strategies which can be adopted in order to improve the pertussis control, by searches of Pubmed, and websites of US and European Centers for Disease Control and Prevention, between 1st January 2002, and 1st March 2013. DISCUSSION: The following vaccination strategies have been retrieved and analysed: the cocooning strategy, the immunization of pregnant women and newborns, vaccination programs for preschool children, adolescents, adults and health-care workers. Cost-effectiveness studies provide some contrasting data, mainly supporting both maternal vaccination and cocooning. Adolescent and/or adult vaccination seems to be cost-effective, however data from observational studies suggest that this vaccination strategy, used alone, leads to a reduced pertussis burden globally, but does not affect the disease incidence in infants. Moreover, substantial logistical and economic difficulties have to be overcome to vaccinate the largest number of individuals.
SUMMARY: The simultaneous use of more than one strategy, including cocooning strategy plus vaccination of adolescents and adults, seems to be the most reasonable preventive measure. The development of new highly immunogenic and efficacious pertussis vaccines continues to be a primary objective for the control of pertussis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530907      PMCID: PMC3623740          DOI: 10.1186/1471-2334-13-151

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  81 in total

Review 1.  A critical literature review of health economic evaluations in pertussis booster vaccination.

Authors:  Aurelie Millier; Samuel Aballea; Lieven Annemans; Mondher Toumi; Sibilia Quilici
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2012-02       Impact factor: 2.217

2.  Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.

Authors:  Yenlik A Zheteyeva; Pedro L Moro; Naomi K Tepper; Sonja A Rasmussen; Faith E Barash; Natalia V Revzina; Dmitry Kissin; Paige W Lewis; Xin Yue; Penina Haber; Jerome I Tokars; Claudia Vellozzi; Karen R Broder
Journal:  Am J Obstet Gynecol       Date:  2012-05-14       Impact factor: 8.661

3.  Cost effectiveness of pertussis vaccination in adults.

Authors:  Grace M Lee; Trudy V Murphy; Susan Lett; Margaret M Cortese; Katrina Kretsinger; Stephanie Schauer; Tracy A Lieu
Journal:  Am J Prev Med       Date:  2007-03       Impact factor: 5.043

4.  Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

Authors:  B A Halperin; A Morris; D Mackinnon-Cameron; J Mutch; J M Langley; S A McNeil; D Macdougall; S A Halperin
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

5.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

Review 6.  Re-emergence of pertussis: what are the solutions?

Authors:  Romina Libster; Kathryn M Edwards
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

7.  Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.

Authors:  P A Scuffham; P B McIntyre
Journal:  Vaccine       Date:  2004-07-29       Impact factor: 3.641

8.  Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.

Authors:  Kenneth W Purdy; Joel W Hay; Marc F Botteman; Joel I Ward
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

9.  Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

Authors:  S K Sharma; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

10.  Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.

Authors:  James D Cherry; Tina Tan; Carl-Heinz Wirsing von König; Kevin D Forsyth; Usa Thisyakorn; David Greenberg; David Johnson; Colin Marchant; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

View more
  60 in total

1.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

2.  Trends in hospital admission rates for whooping cough in England across five decades: database studies.

Authors:  Nick Haslam; Uy Hoang; Michael J Goldacre
Journal:  J R Soc Med       Date:  2014-02-13       Impact factor: 5.344

3.  Using a scripted data entry process to transfer legacy immunization data while transitioning between electronic medical record systems.

Authors:  J Michel; A Hsiao; A Fenick
Journal:  Appl Clin Inform       Date:  2014-03-26       Impact factor: 2.342

4.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.

Authors:  Tara Bancroft; Myles B C Dillon; Ricardo da Silva Antunes; Sinu Paul; Bjoern Peters; Shane Crotty; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Cell Immunol       Date:  2016-05-14       Impact factor: 4.868

Review 5.  [Recent progress in clinical research on pertussis].

Authors:  Dan-Xia Wu; Qiang Chen; Kun-Ling Shen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

6.  Pertussis manifesting as recurrent cough and wheezing in an incompletely vaccinated 8-month-old infant.

Authors:  Dimitri Poddighe; Marco Giuseppe Nedbal; Nunzia Mastricci; Paola Bruni
Journal:  BMJ Case Rep       Date:  2017-10-09

7.  Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.

Authors:  Deepak B Salunke; Seth W Connelly; Nikunj M Shukla; Alec R Hermanson; Lauren M Fox; Sunil A David
Journal:  J Med Chem       Date:  2013-07-10       Impact factor: 7.446

Review 8.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

9.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 10.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.